Navigation Links
Protein Expression to Serve as Marker for Head and Neck Cancer

Recent studies have revealed that the blood of patients with head and neck cancer have some unique patterns of protein expression which could serve as a screening test for this highly aggressive cancer. //

Studies comparing protein expression in 78 patients with head and neck cancer to 68 healthy controls revealed numerous differences in protein expression, Medical College of Georgia researchers say.

‘We found scores and scores of proteins that were differentially expressed,’ says Dr. Christine Gourin, MCG otolaryngologist specializing in head and neck cancer and the study’s lead author. ‘We found there are at least eight proteins whose expression significantly differs between controls and people with cancer.’

This protein fingerprint correctly classified study participants as cancer patients with a high degree of sensitivity and specificity – 82 percent and 76 percent, respectively, according to research published in the current issue of Archives of Otolaryngology.

‘If these results hold up over time, they would suggest that this would be a good screening test for at-risk people,’ Dr. Gourin says. ‘Right now there is no good, effective screening test for head and neck cancer short of physical examination. Unfortunately it takes the development of symptoms to warrant a visit to the doctor, such as a sore throat; ear, tongue or mouth pain; painful eating or swallowing; or a change in the voice. Sometimes the first sign is a lump in the neck which is already a sign of an advanced tumor that has spread to the lymph nodes.’

Belated diagnoses translate to fairly dismal survival rates: less than 50 percent five years following diagnosis of stage three or four tumors, Dr. Gourin says. The rare patient who is diagnosed early faces much better odds: voice box cancer caught in stage one has about a 95 percent five-year survival, for example.

The goal is to screen high-risk populations – those with a history of alcoho
'"/>




Page: 1 2 3

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
3. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of ‘Huntingtons’ Disase
4. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of Huntingtins’ Disese
5. Protein in urine foresees heart disease
6. Levels Of Blood Proteins May Help Heart Disease Care
7. Protein signals need for heart surgery
8. Protein and fat improve memory
9. Clotting Protein plays a role in nerve repair
10. High Levels of Protein Linked to Brain Shrinkage
11. Protein can change worn muscle fibres
Post Your Comments:
(Date:12/3/2008)... RANCHO CORDOVA, Calif., Dec. 3 /PRNewswire-FirstC...leading supplier of innovative products and servic...today that William Osgood, Ph.D.,has reached an a...resign as,the Chief Executive Officer and a direc...oard has named Matthew T. Plavan, the Company,s Ex...
(Date:12/3/2008)... Low erosive effect on teeth and antioxidants prov...Newswire-USNewswire/ -- Today, the average size so... sugar. More startling is that some citric acids f...loric or sulfuric acid -- which is also known as b...in soda and citrus juice promote tooth erosion, wh...
(Date:12/3/2008)... Yet another reason pregnant women should avoid th..., Dec. 3 (HealthDay News) -- Women taking the epil...d risk of delivering a child who develops autism. ... issue of Neurology , add to previous research sh... can contribute to birth defects (particularly neu...
(Date:12/3/2008)... 4 1/2-Year Fight Shows Need for Labor Law Reform ...swire/ -- Healthcare workers at Enloe Medical Cent...l management for a new contract that includes impr... workers, and an average wage increase of 33 perce...ntract would cap more than a year of bargaining th...
Breaking Medicine News(10 mins):Health News:ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones 2Health News:ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones 3Health News:ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones 4Health News:ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones 5Health News:Drink Brewed Tea to Avoid Tooth Erosion 2Health News:Drink Brewed Tea to Avoid Tooth Erosion 3Health News:Epilepsy Drug May Raise Autism Risk in Offspring 2Health News:Epilepsy Drug May Raise Autism Risk in Offspring 3Health News:Healthcare Workers Reach Tentative Agreement With Enloe Medical Center 2
...to a NASA analysis. The other warmest years are 19... Artic region, the year 2005 was reportedly unusua...scientists used temperature data from weather // s...rface temperature since 1982, and data from ships ...
...eloped a fertility predictor test, which enables w...increasing or decreasing. This will be particularl...riages. The best age for child bearing is// report...rofessor Bill Ledger of the Sheffield University. ...
...h the progress of age can be postponed by going in...h the Journal of the American College of Cardiolog...h goes to show that primary aging can // be delaye...ngs, according to researcher Dr Luigi Fontana. T...
...d the administration of flu vaccine to all childre...event the incidence of seasonal flu. The dreadful ...pulation during winter, had claimed the valuable l...ar. The Joint Committee on Vaccination and Immuni...
Other Medicine News:
(Date:12/2/2008)... BETHESDA, Md., Dec. 2 ...cal company developing novel, proprietary antibodi...utoimmune diseases, today announced that it has en...uity Financing Facility (CEFF) with Kingsbridge Ca...the terms of the agreement, Kingsbridge has commit...
(Date:12/1/2008)... SAN DIEGO, Dec. 1 TargeGen has a...y results from a multi-center, US-based clinical,...tients has been scheduled at,the 2008 American So...ils of the presentation are as follows:, Tit...rally Bioavailable, JAK2-S...
(Date:12/1/2008)... St. Jude study shows the Prox1 gene is a two-way...thelial cells to be reprogrammed so that they lose...lial cells , , MEMPHIS, Tenn., Dec. 1 /PRNe...dren,s Research Hospital have discovered that a ce...ge its identity that it requires the constant expr...
(Date:12/1/2008)... -- Conference Call Scheduled for Tuesday, Decemb...ts in AML -- , , SOUTH SAN FRANCISCO, Cali...rmaceuticals, Inc. (Nasdaq: SNSS ), a biopharmac...mercialization of new oncology therapeutics, today...in acute myeloid leukemia (AML) will be presented ...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3UT Houstons Northrup and colleagues uncover genetic link to spina bifida 1656 1UT Houstons Northrup and colleagues uncover genetic link to spina bifida 1656 2Preschool for all would help nation say 2008 Grawemeyer Award winners 8493 1Yale launches landmark VIRGO study of young women with heart disease 8488 1Yale launches landmark VIRGO study of young women with heart disease 8488 2Many States Still Fall Short in Emergency Preparedness 3A Report 8484 1Many States Still Fall Short in Emergency Preparedness 3A Report 8484 2Many States Still Fall Short in Emergency Preparedness 3A Report 8484 3Many States Still Fall Short in Emergency Preparedness 3A Report 8484 4
...007 /PRNewswire/ --,Pieris AG, a bio-pharmaceutica...of targeted human protein therapeutics, announced ...has successfully,demonstrated dual targeting poten... Hohlbaum, Director of,Science and Preclinical Dev...alidate the therapeutic application of its,technol...
...ise of Anacor,s,Boron-Based Chemistry in Developin.../PRNewswire/ -- Anacor,Pharmaceuticals, a privatel...t the journal Science will publish results of rese...linical candidate,kills fungal cells by interferi...or fungal growth. This unique mechanism of,action,...
Other Medicine Technology:Pieris Progresses Development of its Proprietary Biotherapeutics,Platform: Successful Demonstration of Dual Targeting With,Duocalin(R) Technology 2Pieris Progresses Development of its Proprietary Biotherapeutics,Platform: Successful Demonstration of Dual Targeting With,Duocalin(R) Technology 3Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug,AN2690; Findings Published in Science 2Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug,AN2690; Findings Published in Science 3
Galilean Loupes
...agnetom Sonata is a system of unparalleled power, ...iovascular and neuroradiological applications. Mag...ported by previously stored optimized sequences, c...om Sonata is the fastest MR system in the industry...
Inside and out, the Achieva is designed to unleash a new era, in which the clinical capabilities of MR will further expand.
...latelet Concentrate System is a point-of-care syst...Concentrate (also referred to as Platelet Rich Pla...mall sample of blood. The Symphony PCS concentrate...nd in the platelets. The platelet concentrate can ...
Medicine Products: